X0508 4 2025-03-04 0001860871 Tevogen Bio Holdings Inc. TVGN 0002011757 Flomenberg Neal C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BLVD, STE 410 WARREN NJ 07059 0 1 0 0 See Remarks 0 Common Stock 2025-03-04 4 S 0 14639 1.28 D 4239663 D Common Stock 2025-03-05 4 S 0 110659 1.21 D 4129004 D Common Stock 2025-03-06 4 S 0 88519 1.10 D 4040485 D The sales reported on this Form 4 were made solely to satisfy the payment of tax obligations relating to the vesting and subsequent settlement of restricted stock units. Such sales were not made at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (5) to this Form 4. These shares were sold in multiple transactions at prices ranging from $1.27 to $1.32, inclusive. These shares were sold in multiple transactions at prices ranging from $1.16 to $1.29, inclusive. These shares were sold in multiple transactions at prices ranging from $1.06 to $1.19, inclusive. Chief Scientific Officer, Global R&D Lead /s/ Kirti Desai, Attorney-in-Fact 2025-03-06